Support PenkeCrispr Therapeutics AG - Trending symbols
Latest News of Crispr Therapeutics AG
| Date | Title | Read |
|---|---|---|
| 2025-10-10 00:00 | CRISPR Therapeutics AG (CRSP) Sees a More Significant Dip Than Broader Market: Some Facts to Know | Read |
| 2025-10-08 19:02 | Nuvation Bio Inc. (NUVB): A Bull Case Theory | Read |
| 2025-10-03 23:50 | CRISPR Therapeutics AG (CRSP) Stock Falls Amid Market Uptick: What Investors Need to Know | Read |
| 2025-10-02 07:35 | BMO Reaffirms Outperform on CRISPR Therapeutics (CRSP) After Sirius Collaboration | Read |
| 2025-10-01 14:00 | CRISPR Therapeutics to Present Preclinical Data on Alpha-1 Antitrypsin Deficiency (AATD) Utilizing Novel SyNTase Gene Editing Technology at the European Society of Gene and Cell Therapy (ESGCT) 2025 Annual Congress | Read |
| 2025-09-30 16:00 | Could This Beaten-Down Stock Help You Become a Millionaire? | Read |
| 2025-09-29 16:49 | SPDR S&P Biotech ETF Experiences Big Inflow | Read |
| 2025-09-26 23:50 | CRISPR Therapeutics AG (CRSP) Laps the Stock Market: Here's Why | Read |
| 2025-09-25 17:14 | Interesting CRSP Put And Call Options For November 7th | Read |
| 2025-09-17 23:50 | CRISPR Therapeutics AG (CRSP) Falls More Steeply Than Broader Market: What Investors Need to Know | Read |
Notifications
| Type | Notification | Date |
|---|---|---|
| RSI Overbought | Overbought RSI (Relative Strength Index) | 2025-10-09 |
Trends
| 2024-06-30 | 2024-09-30 | 2024-12-31 | 2025-03-31 | 2025-06-30 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Total Other Income Expense Net | 26,139 | -1,075 | 25,064 | 2,913 | 27,977 | -14,440 | 13,537 | -87,723 | -74,186 | |
| Net Debt | -286,179 | 135,334 | -150,845 | -321,655 | -472,500 | 219,331 | -253,169 | 255,044 | 1,875 | |
| Accumulated Other Comprehensive Income | -15,647 | 6,259 | -9,388 | 480 | -8,908 | 2,111 | -6,797 | 8,710 | 1,913 | |
| Income before Tax | -120,051 | 68,306 | -51,745 | -25,072 | -76,817 | -34,923 | -111,740 | 201,320 | 89,580 | |
| Net Income | -110,575 | 57,510 | -53,065 | -24,675 | -77,740 | -34,412 | -112,152 | 201,499 | 89,347 | |
| EBIT | -137,387 | 67,849 | -69,538 | -25,685 | -95,223 | -42,113 | -137,336 | 206,919 | 69,583 | |
| EBITDA | -131,541 | 67,054 | -64,487 | -25,775 | -90,262 | -42,149 | -132,411 | 206,894 | 74,483 | |
| Operating Income | -131,541 | 67,054 | -64,487 | -30,736 | -95,223 | -37,188 | -132,411 | 201,994 | 69,583 | |
| Net Income from Continuing Operations | -110,575 | 57,510 | -53,065 | -24,675 | -77,740 | -34,412 | -112,152 | 201,499 | 89,347 | |
| Gross Profit | -30,468 | -3,296 | -33,764 | -5,001 | -38,765 | 31,948 | -6,817 | 64,625 | 57,808 |
Comments
How you think about this?